Insider · CIK 0001397329
M Michelle Berrey
Files at ICPT (INTERCEPT PHARMACEUTICALS, INC.). First filing -, latest -.
In brief
M Michelle Berrey files SEC Form 4 as president at ICPT (INTERCEPT PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; M Michelle Berrey has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | UTender of shares Common Stock | -28,349 | $19.00 | $539k | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Common Stock | -51,790 | $19.00 | $984k | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -17,600 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -24,000 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -93,000 | - | - | 0 | Nov 13, 2023 |
Questions about M Michelle Berrey
Answered from the filings on this page, as of the latest one.
Is M Michelle Berrey buying or selling?
M Michelle Berrey has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did M Michelle Berrey's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and M Michelle Berrey has 0.
Where does M Michelle Berrey file Form 4?
M Michelle Berrey has filed Form 4 at ICPT (INTERCEPT PHARMACEUTICALS, INC.) as President, R&D and CMO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.